JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
Cognizant
CTSH
$26.7B
| $10.4M | ﹤0.01% |
167,800
| – | – |
|
2002
Korn Ferry
KFY
$4.36B
| $10.4M | ﹤0.01% |
244,659
-58,615
| -19% | -$2.27M |
|
2003
iShares Short Maturity Bond ETF
NEAR
$4.88B
| $10.4M | ﹤0.01% |
206,219
+37,405
| +22% | +$1.88M |
|
|
SEM
2004
DELISTED
Select Medical
SEM
| $10.4M | ﹤0.01% |
823,340
+38,813
| +5% | +$418K |
|
2005
Etsy
ETSY
$7.4B
| $10.3M | ﹤0.01% |
233,620
-367,966
| -61% | -$17.5M |
|
2006
iShares US Financials ETF
IYF
$4.44B
| $10.3M | ﹤0.01% |
149,550
+4,050
| +3% | +$269K |
|
|
GLDD
2007
DELISTED
Great Lakes Dredge & Dock
GLDD
| $10.3M | ﹤0.01% |
907,459
-677,109
| -43% | -$7.23M |
|
|
DNKN
2008
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $10.3M | ﹤0.01% |
135,993
-16,839
| -11% | -$1.27M |
|
|
MDP
2009
DELISTED
Meredith Corporation
MDP
| $10.3M | ﹤0.01% |
316,264
-18,175
| -5% | -$647K |
|
2010
PUT
Humana
HUM
$46.2B
| $10.3M | ﹤0.01% |
28,000
| – | – |
|
|
DTP
2011
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $10.3M | ﹤0.01% |
+200,000
| New | +$10M |
|
2012
Integra LifeSciences
IART
$1.42B
| $10.2M | ﹤0.01% |
175,788
-11,298
| -6% | -$673K |
|
2013
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $10.2M | ﹤0.01% |
333,534
+101,712
| +44% | +$3M |
|
|
WTRE
2014
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $10.2M | ﹤0.01% |
405,667
-60,740
| -13% | -$1.61M |
|
|
S
2015
PUT
DELISTED
Sprint Corporation
S
| $10.2M | ﹤0.01% |
1,955,000
+665,000
| +52% | +$3.9M |
|
2016
Ligand Pharmaceuticals
LGND
$5.76B
| $10.2M | ﹤0.01% |
156,313
+7,814
| +5% | +$522K |
|
2017
Casey's General Stores
CASY
$31.6B
| $10.2M | ﹤0.01% |
63,880
-3,399
| -5% | -$563K |
|
2018
Knowles
KN
$3.23B
| $10.2M | ﹤0.01% |
479,979
+171,514
| +56% | +$3.68M |
|
|
BEAT
2019
DELISTED
BioTelemetry, Inc.
BEAT
| $10.1M | ﹤0.01% |
219,224
-30,597
| -12% | -$1.32M |
|
2020
The Bancorp
TBBK
$2.82B
| $10.1M | ﹤0.01% |
782,031
-83,615
| -10% | -$938K |
|
2021
Simmons First National
SFNC
$3.46B
| $10.1M | ﹤0.01% |
378,588
+148,503
| +65% | +$3.75M |
|
2022
PUT
Vertex Pharmaceuticals
VRTX
$131B
| $10.1M | ﹤0.01% |
46,300
+20,000
| +76% | +$4.05M |
|
|
EVF
2023
Eaton Vance Senior Income Trust
EVF
$90.9M
| $10.1M | ﹤0.01% |
1,579,470
| – | – |
|
2024
Cameco
CCJ
$42.6B
| $10.1M | ﹤0.01% |
1,133,435
+122,013
| +12% | +$1.13M |
|
2025
CALL
Tanger
SKT
$4.42B
| $10.1M | ﹤0.01% |
684,000
+234,600
| +52% | +$3.67M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.